Every Teladoc Investor Should Keep an Eye on This Number

As a pandemic-era star fallen from grace in recent times, Teladoc Health (NYSE: TDOC) nevertheless remains prominent in the telehealth space -- in fact, for many, it's a bellwether for the segment. Its stock also staged something of a rally at the end of October, buoyed by better-than-expected third-quarter results. As always, investors focused on the company's revenue and bottom-line performance. While both of those line items are important, another factor is a more compelling watch with Teladoc.Teladoc's major weakness these days is BetterHelp, the smaller (and worse-performing) of its two business segments, which concentrates on mental health services.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool